Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis: Comment on the article by Gutierrez‐Ureña et al
- 1 January 1997
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 40 (1) , 193-194
- https://doi.org/10.1002/art.1780400129
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Methotrexate-induced bone-marrow suppressionClinical and Laboratory Haematology, 2008
- Pancytopenia secondary to methotrexate therapy in rheumatoid arthritisArthritis & Rheumatism, 1996
- Pancytopenia from Using Trimethoprim and MethotrexateAnnals of Internal Medicine, 1992
- Methotrexate and Nonsteroidal Antiinflammatory Drug InteractionsAnnals of Pharmacotherapy, 1992
- Haemopoietic toxicity and low‐dose methotrexateThe Medical Journal of Australia, 1992
- Pancytopenia after accidental overdose of methotrexate A complication of low‐dose therapy for rheumatoid arthritisThe Medical Journal of Australia, 1991
- Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapyArthritis & Rheumatism, 1989
- Low-dose methotrexate treatment of rheumatoid arthritis; Long-term observation of efficacy and safetyClinical Rheumatology, 1989
- Methotrexate-associated, early-onset pancytopenia in rheumatoid arthritisArchives of internal medicine (1960), 1989
- Methotrexate‐associated bone marrow suppression following surgeryArthritis & Rheumatism, 1988